MTOR and cancer: In a previous study, pharmacological inhibition of the mTOR pathway using the dual PI3K/mTOR inhibitor LY3023414 induced DNA damage and enhanced CHK1 inhibitor-induced replication stress and cancer cell death in HGSOC models, including OVCAR8 and PEO1 cells [20].